SIMNOVA

Simnova is a clinical stage biotech company focusing on the development of cell therapy for cancer patients... Simnova Biotechnology was founded in 2019, which as a subsidiary of Simcere Pharmaceuticals, then spun off into an independent operating company in 2021. There are research centers in Shanghai, China and Boston, USA. In addition to focusing on the development of CAR-NK and next-generation mRNA in vivo cell therapy products with global competitiveness, the company is also actively promoting the clinical research and application of solid tumor CAR-T projects, striving to bring effective, safe and accessible innovative cell therapy drugs to patients with hematological and solid tumors as soon as possible.

Primary location: Cambridge United States